Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
tcpkUwUcmz8RwCsp
